1989-1996: Patent and Licensing Departments of Hoechst AG and the affiliate Behringwerke AG

1996-1999: Private practice and Associate of the firm "Bardehle, Pagenberg, Dost, Altenburg, Geissler, Isenbruck" in Munich

1999-2002: Partner in the firm "Bardehle, Pagenberg, Dost, Altenburg, Geissler, Isenbruck" in Munich

since 2003: Partner in the firm "Isenbruck Bösl Hörschler Wichmann LLP" in Munich

1980-1989: Studies of Chemistry and Biochemistry at the University of Munich, Germany

1986: Degree of Diplom-Chemiker; Diploma thesis in Biochemistry

1986-1989: Graduate Scholarship of the Hanns-Seidel-Stiftung

1989: Degree of Dr. rer. nat.; Thesis in Molecular Biology

1990: Four months training in US patent law and passing a training course at the Patent Academy of the US-PTO

1993: Admitted as European Patent Attorney

1998: Admitted to the German Bar of Patent Attorneys

The German Biotechnology-Industry-
Organisation (BIO Deutschland e.V.); Member of the Specialized Comittee "Protection rights and technical contracts"

International Federation of Industrial Property Attorneys (FICPI)

Association of German Chemists (GDCh) - Intellectual Property Group

German Association for the Protection of Intellectual Property and Copyright Law (GRUR)

International Trademark Association (INTA)

Licensing Executives Society (LES)

Association of Patent Agents in Industry (VPP)

Doctoral thesis on "Detection and Characterization of an RNA Polymerase stimulating and DNA binding activity from Nicotiana tabacum", 1989

"The Unclear Patent Claim", Mitteilungen, 174-176, 1997

"EST's - A Problem in Patent Law?", VPP Rundbrief, 50-53, 1998

"Patents - Products - Contracts", World Markets Series, BUSINESS BRIEFING, Pharma Tech, World Markets Research Centre, London, April 1999 (CD-ROM)

"The Patentability of Transgene Plants according to the EPC", R. Bösl & A. Schäfers, epi Information, No. 2, 65-68, June 1999

"Implementing the EU Biotech Directive" in Life Science Contacts Handbook 2001, p. 25, J. Nurton, ed., Managing Intellectual Property

"Die unfertige Erfindung - ein Problem der gewerblichen Anwendbarkeit?", R. Bösl & A. Teschemacher, BIOforum, No. 9., 558-559, 2001

"Biotech Directive Prompts Changes to Utility Models", Life Science Law Review, October 2001

Various national and international lectures on Patents and Licensing Practices